EKSUNBI
LIVE

Serial Number

79384560

Owner

SAMSUNG BIOEPIS CO., LTD.

Filing Date

Nov 1, 2023

Add to watchlist:

No watchlists yet
View on USPTO

EKSUNBI Trademark

Serial Number: 79384560 • Registration: 7525854

EKSUNBI is a trademark filed by SAMSUNG BIOEPIS CO., LTD. on November 1, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

SAMSUNG BIOEPIS CO., LTD. (58 trademarks)

76, Songdogyoyuk-ro, Yeonsu-gu

Entity Type: 03

Trademark Details

Filing Date

November 1, 2023

Registration Date

October 8, 2024

Published for Opposition

July 23, 2024

Goods & Services

Pharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory, respiratory, and transplantation-related diseases and disorders; pharmaceutical preparations for the treatment of generalized myasthenia gravis; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the treatment of ulcerative colitis; antidiabetic preparations; human vaccine preparations; pharmaceutical preparations, namely, pharmaceutical preparations, biological formulations, biological preparations, antibody formulations and protein formulations for immunoregulation and for treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; anti-inflammatory preparations; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for the treatment of diseases of the metabolic system; medicated pharmaceutical preparations for skin treatment; pharmaceutical preparations for psoriasis treatment; pharmaceutical preparations for the treatment of psoriatic arthritis; pharmaceutical preparations for the treatment of crohn's disease; dietary supplements

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 24, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 6, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 6, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 7, 2024 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 8, 2024 R.PR
PUBLISHED FOR OPPOSITION
Jul 23, 2024 PUBO
NOTICE OF PUBLICATION
Jul 3, 2024 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 15, 2024 CNSA
ASSIGNED TO EXAMINER
Jun 7, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 19, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 15, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 14, 2023 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 7, 2023 REPR